Literature DB >> 12196727

A case of pulmonary metastasis from breast cancer following an 18-year disease-free interval that responded to tamoxifen treatment.

Masaki Tomita1, Yasunori Matsuzaki, Masao Edagawa, Masayuki Maeda, Tetsuya Shimizu, Masaki Hara, Atsushi Yamamoto, Toshio Onitsuka.   

Abstract

A 61-year-old woman was admitted to our hospital with an abnormal shadow on chest roentgenogram. She had undergone a radical mastectomy for right breast cancer 18 years previously. Since pleural dissemination was noted at the time of thoracotomy, only tumor biopsy was performed. Although a decisive diagnosis could not be obtained histologically, the tumor resembled breast cancer and the estrogen receptor status was positive. She underwent post-operative chemotherapy and tamoxifen treatment. After tamoxifen treatment, complete response was observed. The patient is now doing well without recurrence about 10 years after thoracotomy. Based on the clinical course, we obtained both a definitive diagnosis and complete remission.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196727     DOI: 10.1007/bf02967552

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  3 in total

1.  Pulmonary metastasis from breast cancer with an 18-year disease-free interval: implication of the role of surgery.

Authors:  Takaaki Fujii; Reina Yajima; Ei Yamaki; Takayuki Kohsaka; Satoru Yamaguchi; Soichi Tsutsumi; Akira Mogi; Takayuki Asao; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2012 Oct-Dec

2.  Sole metastatic pulmonary nodules from breast cancer simulating primary lung adenocarcinoma: Two case reports.

Authors:  Kunihiko Miyazaki; Hiroaki Satoh; Hiroko Watanabe; Toshihiro Shiozawa; Tomohiro Tamura; Mio Kawaguchi; Nobuyuki Hizawa
Journal:  Mol Clin Oncol       Date:  2017-02-03

3.  Pulmonary resection and systemic lymph node dissection in a patient with breast cancer who had a 33-year disease-free interval.

Authors:  Degang Yin; Guofei Zhang; Lufeng Zhao; Ying Chai
Journal:  World J Surg Oncol       Date:  2015-04-16       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.